Michael R. Charley

461 total citations
16 papers, 404 citations indexed

About

Michael R. Charley is a scholar working on Immunology, Oncology and Dermatology. According to data from OpenAlex, Michael R. Charley has authored 16 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 6 papers in Dermatology. Recurrent topics in Michael R. Charley's work include Cutaneous lymphoproliferative disorders research (6 papers), Immunotherapy and Immune Responses (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Michael R. Charley is often cited by papers focused on Cutaneous lymphoproliferative disorders research (6 papers), Immunotherapy and Immune Responses (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Michael R. Charley collaborates with scholars based in United States. Michael R. Charley's co-authors include Dwain L. Thiele, Brian V. Jegasothy, Michael D. Tharp, Jau‐Shyong Deng, Peter E. Lipsky, James N. Gilliam, M. Catherine Bennett, Michael V. L. Bennett, R D Sontheimer and Timothy J. Sullivan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

Michael R. Charley

16 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael R. Charley United States 12 261 127 91 90 79 16 404
Nickoloff Bj United States 8 210 0.8× 100 0.8× 85 0.9× 56 0.6× 13 0.2× 10 413
Klemens Rappersberger Austria 9 85 0.3× 55 0.4× 53 0.6× 129 1.4× 51 0.6× 13 364
Soji Kurita Japan 10 126 0.5× 63 0.5× 225 2.5× 231 2.6× 34 0.4× 14 447
EA Sausville United States 6 331 1.3× 108 0.9× 104 1.1× 132 1.5× 48 0.6× 8 482
Changsheng Guo China 7 378 1.4× 217 1.7× 91 1.0× 52 0.6× 33 0.4× 11 593
Isabel Longo Spain 8 160 0.6× 72 0.6× 203 2.2× 29 0.3× 17 0.2× 12 382
Jutta Schröder Germany 9 241 0.9× 38 0.3× 133 1.5× 57 0.6× 10 0.1× 10 342
Thomas L. Olson United States 12 374 1.4× 29 0.2× 143 1.6× 300 3.3× 90 1.1× 22 604
L A Turka United States 6 435 1.7× 55 0.4× 68 0.7× 15 0.2× 17 0.2× 7 567
Frédérique‐Marie Rattis France 8 788 3.0× 75 0.6× 349 3.8× 19 0.2× 70 0.9× 10 903

Countries citing papers authored by Michael R. Charley

Since Specialization
Citations

This map shows the geographic impact of Michael R. Charley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Charley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Charley more than expected).

Fields of papers citing papers by Michael R. Charley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Charley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Charley. The network helps show where Michael R. Charley may publish in the future.

Co-authorship network of co-authors of Michael R. Charley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Charley. A scholar is included among the top collaborators of Michael R. Charley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Charley. Michael R. Charley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tendler, Craig, J. D. Burton, Jonathan S. Jaffe, et al.. (1994). Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.. PubMed. 54(16). 4430–5. 40 indexed citations
2.
Charley, Michael R., et al.. (1993). Elevated serum soluble interleukin-2 receptor levels in subacute cutaneous lupus erythematosus. Journal of Dermatological Science. 5(3). 143–149. 5 indexed citations
3.
Hunt, Steven J., Michael R. Charley, & Brian V. Jegasothy. (1992). Cutaneous T-cell lymphoma: Utility of antibodies to the variable regions of the human T-cell antigen receptor. Journal of the American Academy of Dermatology. 26(4). 552–558. 17 indexed citations
4.
Charley, Michael R., Michael D. Tharp, Joseph Locker, et al.. (1990). Establishment of a Human Cutaneous T-Cell Lymphoma in C.B-17 SCID Mice. Journal of Investigative Dermatology. 94(3). 381–384. 50 indexed citations
5.
Charley, Michael R., et al.. (1990). Possible Role of Epstein-Barr Virus Infection in Cutaneous T-Cell Lymphomas. Journal of Investigative Dermatology. 95(3). 309–312. 44 indexed citations
6.
Charley, Michael R., J. Philip McCoy, Jau‐Shyong Deng, & Brian V. Jegasothy. (1990). Anti-V Region Antibodies as “Almost Clonotypic” Reagents for the Study of Cutaneous T Cell Lymphomas and Leukemias. Journal of Investigative Dermatology. 95(5). 614–617. 22 indexed citations
7.
Tharp, Michael D., et al.. (1989). Studies of Connective Tissue Mast Cell-Mediated Cytotoxicity.. Journal of Investigative Dermatology. 93(3). 423–428. 17 indexed citations
8.
Tharp, Michael D., et al.. (1989). Studies of connective tissue mast cell-mediated cytotoxicity. Journal of Investigative Dermatology. 93(3). 423–428. 26 indexed citations
9.
Charley, Michael R., et al.. (1988). Mechanism of Anti-asialo GM1 Prevention of Graft-vs-Host Disease: Identification of Allo-antigen Activated T Cells. Journal of Investigative Dermatology. 91(3). 202–206. 16 indexed citations
10.
Cruz, Ponciano D., Michael R. Charley, & Paul R. Bergstresser. (1987). Basic science conferences in residency training: A national survey. Journal of the American Academy of Dermatology. 16(2). 413–419. 8 indexed citations
11.
Thiele, Dwain L., et al.. (1987). Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.. The Journal of Immunology. 138(1). 51–57. 53 indexed citations
12.
Charley, Michael R., Dwain L. Thiele, Michael V. L. Bennett, & Peter E. Lipsky. (1986). Prevention of lethal murine graft versus host disease by treatment of donor cells with L-leucyl-L-leucine methyl ester.. Journal of Clinical Investigation. 78(5). 1415–1420. 24 indexed citations
13.
Charley, Michael R., et al.. (1985). Studies Addressing the Mechanism of Anti-Asialo GM1 Prevention of Graft-Versus-Host Disease Due to Minor Histocompatibility Antigenic Differences. Journal of Investigative Dermatology. 85(1). S121–S123. 8 indexed citations
14.
Charley, Michael R., et al.. (1983). Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.. The Journal of Immunology. 131(5). 2101–2103. 45 indexed citations
15.
Charley, Michael R., et al.. (1983). Murine Graft-Versus-Host Skin Disease: A Chronologic and Quantitative Analysis of Two Histologic Patterns. Journal of Investigative Dermatology. 81(5). 412–417. 27 indexed citations
16.
Charley, Michael R. & Richard D. Sontheimer. (1982). Clearing of subacute cutaneous lupus erythematosus around molluscum contagiosum lesions. Journal of the American Academy of Dermatology. 6(4). 529–533. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026